← Feed/DEA2024/2606(DEA)Health & Social

Amendment: Inclusion of IMDPAM and other drug precursors in scheduled substances

COMCMT1R-EP1R-C2R-EPCNCADO

Updated 28mo ago

This decision adds new substances to the EU's list of controlled drug precursors to prevent their use in making illegal drugs. The aim is to keep EU drug control laws up-to-date with new chemicals designed to bypass existing regulations.

The substances affected include Isopropylidene (2-(3,4-methylenedioxyphenyl)acetyl)malonate (IMDPAM), its sodium salt, and certain esters related to BMK and PMK glycidic acid. These are identified as being used in the production of MDMA, methamphetamine, and amphetamine.

The law updates existing regulations on drug precursors, subjecting IMDPAM and the identified esters to harmonised control and monitoring measures. This means stricter rules will apply to their trade and handling within the EU and with third countries.

These new controls are intended to enter into force as soon as possible to quickly prevent the misuse of these substances for illicit drug production and trafficking.

Documents

Amendment to Regulation (EC) No 273/2004 (+1 more)

position · EN · 2026-04-01

↗

Analysis

AI-generated·2 Apr 2026·Source document·Unverified

The European Parliament declares that it has no objections to the Commission delegated regulation amending Regulation (EC) No 273/2004 and Council Regulation (EC) No 111/2005.

What changes

Inclusion of Isopropylidene (2-(3,4-methylenedioxyphenyl)acetyl)malonate (IMDPAM), seven esters of 2-methyl-3-phenyloxirane-2-carboxylic acid (BMK glycidic acid), and six esters of 3-(1,3-benzodioxol-5-yl)-2-methyl-oxirane-2-carboxylic acid (PMK glycidic acid) in the list of scheduled substances under Regulation (EC) No 273/2004 and Council Regulation (EC) No 111/2005.

Expected impact

The amendment subjects IMDPAM and identified esters of BMK glycidic acid and PMK glycidic acid to harmonised control and monitoring measures provided for by Regulation (EC) No 273/2004 and Council Regulation (EC) No 111/2005.
The control measures for newly scheduled substances under Regulations (EC) No 273/2004 and (EC) No 111/2005 are intended to enter into force as soon as possible to prevent their use for the production and placing on the market of illicit drugs.
The European Commission committed to fast-tracking the adoption procedure of future delegated acts scheduling additional substances under Regulations (EC) No 273/2004 and (EC) No 111/2005.

Limitations

The specific text of the Commission delegated regulation (C(2024)01219) is not provided, only the European Parliament's decision on it.
The exact nature of the 'harmonised control and monitoring measures' is not detailed in the provided text.
The document does not specify the exact date of entry into force for the new scheduled substances, only that it should be 'as soon as possible'.

Learn more

How EU laws are made Reading voting records What is a trilogue?